Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 10—October 2019

Edwardsiella tarda Bacteremia, Okayama, Japan, 2005–2016

Shinya KamiyamaComments to Author , Akira Kuriyama, and Toru Hashimoto
Author affiliations: Kurashiki Central Hospital, Okayama, Japan

Main Article

Table 2

Clinical characteristics of 26 patients with Edwardsiella tarda bacteremia, Kurashiki Central Hospital, Okayama, Japan, 2005–2016*

Patient no. Age, y/sex Clinical diagnosis Underlying disease Treatment Treatment
duration, d Concurrent organisms (source) Outcome
1 77/M Focus unknown Cerebrovascular disease LVX 3 E. coli, B. fragilis (pus) Recovered
2 79/M Liver abscess Cardiovascular disease CFP/SUL→IPM/CIL→PIP→MEP, CLI→MEM 38 Recovered
3 70/F Cholangitis,
cholecystitis None CFP/SUL 8 Recovered
4 87/M Focus unknown Hepatocellular carcinoma FEP 11 Died at 12 d
5 62/M Mycotic aneurysm,
liver abscess,
osteomyelitis Diabetes mellitus IPM/CIL→AMP, GEN→SAM→VCM, PNP→VCS→PZX 30 Died at 39 d
6 92/F Focus unknown Colon cancer CRO 30 Died at 32 d
7 89/F Focus unknown Colon cancer CRO→MEM 16 Recovered
8 85/F Liver abscess,
enterocolitis Thyroid cancer MEM, CLI→MEM→IPM/CIL 21 Recovered
9 88/F Cholangitis Cholangiocarcinoma IPM/CIL 7 Died at 40 d
10 75/F Cholecystitis None PZX 3 Klebsiella sp.,
E. coli (bile) Recovered
11 101/F Cholangitis None CFP/SUL 10 Recovered
12 61/M Enterocolitis Cardiovascular disease CRO→LVX 10 Recovered
13 58/M Liver abscess Gallbladder cancer、
invasion of liver CFP/SUL→MEM→MIN→AMP, MIN 77 E. faecalis,
E. faecium,
C. freundii, Bacteroides sp. (pus) Recovered
14 84/F Cholangitis Cardiovascular disease,
cerebrovascular disease CRO 6 Recovered
15 83/F Cholangitis Pancreatic cancer CFP/SUL 1 Recovered
16 66/M Liver abscess Pancreatic cancer CFZ→LEX 46 Recovered
17 85/M Enterocolitis Cardiovascular disease CRO→LVX 12 Recovered
18 64/F Enterocolitis Chronic liver disease,
diabetes mellitus CMZ→AMP 13 Recovered
19 74/F Secondary peritonitis Diabetes mellitus CMZ→TZP 27 E. coli,
K. pneumoniae,
S. anginosus,
F. nucleatum (ascites) Recovered
20 63/M Necrotizing fasciitis None MEM, CLI 2 Died at 2 d
21 45/F Liver abscess, cholangitis Pancreatic cancer CFP/SUL→AMP 31 S. anginosus (blood) Died at 45 d
22 65/M Cholangitis, cholecystitis Gastric cancer,
gallstone CFP/SUL→AMP 13 S. gallolyticus (blood) Recovered
23 81/M Cholangitis Gallstone,
esophageal cancer CFP/SUL→AMP 16 Recovered
24 64/M Cholangitis Cholangiocarcinoma, gallstone CFP/SUL→AMP 8 Recovered
25 59/M Focus unknown,
febrile neutropenia Peripheral T-cell lymphoma CZO 12 Recovered
26 60/F Spontaneous bacterial peritonitis,
empyema Chronic liver disease TZP→AMP 5 Died at 6 d

*AMP, ampicillin; B. fragilis, Bacteroides fragilis; CFP/SUL, cefoperazon–sulbactam; C. freundii, Citrobacter freundii; CFZ, cefazolin; CLI, clindamycin; CMZ, cefmetazole; CRO, ceftriaxone; CZO, cefozopran; E. faecalis, Enterococcus faecalis; E. faecium, Enterococcus faecium; E. coli, Escherichia coli; FEP, cefepime; F. nucleatum, Fusobacterium nucleatum; GEN, gentamycin; IPM/CIL, imipenem–cilastatin; K. pneumoniae, Klebsiella pneumoniae; LEX, cephalexin; LVX, levofloxacin; MEM, meropenem; MIN, minocycline; PNP, panipenem; PIP, piperacillin; PZX, pazufloxacin, SAM, ampicillin sulbactam; S. anginosus, Streptococcus anginosus; S. gallolyticus, Streptococcus gallolyticus; Tx, treatment; TZP, piperacillin tazobactam. Arrows indicate the order of antimicrobial drugs used. Blank cells indicate no other concurrent organisms.

Main Article

Page created: September 12, 2019
Page updated: September 12, 2019
Page reviewed: September 12, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.